Table 6.

Plasma cholesterol and triacylglycerol in minipigs treated with G. lucidum and lovastatin (mmol/L)

Group	TC	TC	TC	TC	TAG	TAG	TAG	TAG	VLDL	VLDL	LDL	LDL	HDL	HDL	LDL/HDL	LDL/HDL
	D1	D14	D21	D29	D1	D14	D21	D29	D14	D29	D14	D29	D14	D29	D14	D29
Gl (2.5%)	2.47a	3.21bc	2.81	2.58	0.53	0.57	0.80	0.69	0.07	0.09	1.45c	1.08	1.69c	1.42	0.88	0.79
Lovastatin	2.36a	3.00	2.44	2.81	0.50	0.60	0.59	0.71	0.10	0.09	1.40	1.29	1.50	1.43	0.95	0.91

Lovastatin was administered at 80 mg/d. Between D1-14, all pigs received a high cholesterol and fat control diet; from D15-29, pigs received either G. lucidum (Gl) extract or lovastatin. The same statistical conclusions were reached if all 10 pigs were compared between D1-14. Pigs were randomly selected to receive either GI or lovastatin before study commencement. Student's, paired, 1-tailed, t-test, was utilized for statistical comparisons. Statistically significant changes (P < 0.05, 1-tailed testing) in cholesterol parameters are indicated as follows: ^aD1 vs. 14; ^bD14 vs. 21; ^cD14 vs. 29. Abbreviations: refer to Table 3. There was a slight trend for 2.5% Gl to reduce LDL/HDL ratio between D14-29 (P < 0.11, 1-tailed testing).